HEADER PROTEIN BINDING/INHIBITOR 05-AUG-14 4R1E TITLE CRYSTAL STRUCTURE OF MTIP FROM PLASMODIUM FALCIPARUM IN COMPLEX WITH A TITLE 2 PEPTIDE-FRAGMENT CHIMERA COMPND MOL_ID: 1; COMPND 2 MOLECULE: MYOSIN A TAIL DOMAIN INTERACTING PROTEIN; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: UNP RESIDUES 61-204; COMPND 5 ENGINEERED: YES; COMPND 6 MOL_ID: 2; COMPND 7 MOLECULE: MYOSIN-A; COMPND 8 CHAIN: B; COMPND 9 FRAGMENT: UNP RESIDUES 803-816; COMPND 10 SYNONYM: PFM-A; COMPND 11 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: PLASMODIUM FALCIPARUM; SOURCE 3 ORGANISM_TAXID: 36329; SOURCE 4 STRAIN: ISOLATE 3D7; SOURCE 5 GENE: MTIP, PFL2225W; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21 (DE3); SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PRSETA; SOURCE 11 MOL_ID: 2; SOURCE 12 SYNTHETIC: YES; SOURCE 13 ORGANISM_SCIENTIFIC: PLASMODIUM FALCIPARUM ISOLATE 3D7; SOURCE 14 ORGANISM_TAXID: 36329 KEYWDS CALMODULIN-LIKE, PROTEIN BINDING, MYOSIN MOTOR, FRAGMENT PEPTIDE, KEYWDS 2 MEMBRANE, PROTEIN BINDING-INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR C.H.DOUSE,N.VRIELINK,E.COTA,E.W.TATE REVDAT 5 20-SEP-23 4R1E 1 REMARK SEQADV LINK REVDAT 4 22-NOV-17 4R1E 1 REMARK REVDAT 3 23-AUG-17 4R1E 1 REMARK REVDAT 2 14-JAN-15 4R1E 1 JRNL REVDAT 1 12-NOV-14 4R1E 0 JRNL AUTH C.H.DOUSE,N.VRIELINK,Z.WENLIN,E.COTA,E.W.TATE JRNL TITL TARGETING A DYNAMIC PROTEIN-PROTEIN INTERACTION: FRAGMENT JRNL TITL 2 SCREENING AGAINST THE MALARIA MYOSIN A MOTOR COMPLEX. JRNL REF CHEMMEDCHEM V. 10 134 2015 JRNL REFN ISSN 1860-7179 JRNL PMID 25367834 JRNL DOI 10.1002/CMDC.201402357 REMARK 2 REMARK 2 RESOLUTION. 1.98 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.8.0049 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.98 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 44.93 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 96.8 REMARK 3 NUMBER OF REFLECTIONS : 9909 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.199 REMARK 3 R VALUE (WORKING SET) : 0.196 REMARK 3 FREE R VALUE : 0.223 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 9.800 REMARK 3 FREE R VALUE TEST SET COUNT : 1079 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.98 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.03 REMARK 3 REFLECTION IN BIN (WORKING SET) : 735 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 98.30 REMARK 3 BIN R VALUE (WORKING SET) : 0.1840 REMARK 3 BIN FREE R VALUE SET COUNT : 74 REMARK 3 BIN FREE R VALUE : 0.2310 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 1188 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 12 REMARK 3 SOLVENT ATOMS : 67 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 17.27 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.27000 REMARK 3 B22 (A**2) : -0.42000 REMARK 3 B33 (A**2) : 0.15000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.210 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.166 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.107 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 3.664 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.930 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.925 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 1231 ; 0.008 ; 0.020 REMARK 3 BOND LENGTHS OTHERS (A): 1114 ; 0.004 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 1662 ; 1.177 ; 1.960 REMARK 3 BOND ANGLES OTHERS (DEGREES): 2550 ; 1.011 ; 3.003 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 156 ; 5.457 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 56 ;27.645 ;25.536 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 202 ;11.907 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 4 ;29.313 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 189 ; 0.062 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 1424 ; 0.005 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): 279 ; 0.002 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 630 ; 0.875 ; 1.767 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): 629 ; 0.856 ; 1.765 REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 784 ; 1.465 ; 2.634 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): 785 ; 1.466 ; 2.636 REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 601 ; 1.023 ; 1.796 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): 602 ; 1.022 ; 1.799 REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): 879 ; 1.659 ; 2.665 REMARK 3 LONG RANGE B REFINED ATOMS (A**2): 1450 ; 3.277 ;14.002 REMARK 3 LONG RANGE B OTHER ATOMS (A**2): 1439 ; 3.191 ;13.945 REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 4R1E COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 11-AUG-14. REMARK 100 THE DEPOSITION ID IS D_1000086777. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 23-APR-12 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : DIAMOND REMARK 200 BEAMLINE : I04-1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.920 REMARK 200 MONOCHROMATOR : DOUBLE CRYSTAL SI(111) REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : PILATUS 2M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 11020 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.980 REMARK 200 RESOLUTION RANGE LOW (A) : 44.930 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 97.6 REMARK 200 DATA REDUNDANCY : 3.000 REMARK 200 R MERGE (I) : 0.04200 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 13.2000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.98 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.09 REMARK 200 COMPLETENESS FOR SHELL (%) : 97.9 REMARK 200 DATA REDUNDANCY IN SHELL : 3.20 REMARK 200 R MERGE FOR SHELL (I) : 0.10600 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 6.900 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: PDB ENTRY 4AOM REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 42.21 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.13 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.2M AMMONIUM SULFATE, 20% PEG3350, PH REMARK 280 7.5, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 18.35500 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 37.93000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 27.88000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 37.93000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 18.35500 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 27.88000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 2160 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 8300 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -15.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 60 REMARK 465 GLU A 69 REMARK 465 GLU A 70 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 SER A 61 OG REMARK 470 VAL A 62 CG1 CG2 REMARK 470 ASP A 64 CG OD1 OD2 REMARK 470 ILE A 65 CG1 CG2 CD1 REMARK 470 GLN A 66 CG CD OE1 NE2 REMARK 470 GLN A 67 CG CD OE1 NE2 REMARK 470 LEU A 68 CG CD1 CD2 REMARK 470 LYS A 71 CG CD CE NZ REMARK 470 VAL A 72 CG1 CG2 REMARK 470 ASP A 73 CG OD1 OD2 REMARK 470 GLU A 74 CG CD OE1 OE2 REMARK 470 LYS A 89 CE NZ REMARK 470 LYS A 101 CD CE NZ REMARK 470 LYS A 112 CG CD CE NZ REMARK 470 LYS A 115 CG CD CE NZ REMARK 470 ASP A 120 CG OD1 OD2 REMARK 470 GLU A 125 OE1 OE2 REMARK 470 ILE A 133 CG1 CG2 CD1 REMARK 470 LYS A 138 CE NZ REMARK 470 LYS A 146 CE NZ REMARK 470 LYS A 165 CE NZ REMARK 470 GLU A 190 CG CD OE1 OE2 REMARK 470 LYS A 196 CG CD CE NZ REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 3EC B 901 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR CHAIN B OF MYOSIN-A REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 4AOM RELATED DB: PDB REMARK 900 THE SAME PROTEIN IN COMPLEX WITH THE WILD-TYPE MYOA TAIL PEPTIDE REMARK 900 RELATED ID: 4MZJ RELATED DB: PDB REMARK 900 THE SAME PROTEIN IN COMPLEX WITH A STAPLED MYOA TAIL PEPTIDE REMARK 900 RELATED ID: 4MZK RELATED DB: PDB REMARK 900 THE SAME PROTEIN IN COMPLEX WITH A STAPLED MYOA TAIL PEPTIDE REMARK 900 RELATED ID: 4MZL RELATED DB: PDB REMARK 900 THE SAME PROTEIN IN COMPLEX WITH A HYDROGEN BOND SURROGATE MYOA REMARK 900 TAIL PEPTIDE REMARK 999 REMARK 999 SEQUENCE REMARK 999 GLY802 IS NOT PART OF THE NATURAL SEQUENCE OF THE PROTEIN FROM REMARK 999 WHICH THE PEPTIDE IS DERIVED DBREF 4R1E A 61 204 UNP Q8I4W8 Q8I4W8_PLAF7 61 204 DBREF 4R1E B 803 816 UNP Q8IDR3 MYOA_PLAF7 803 816 SEQADV 4R1E GLY A 60 UNP Q8I4W8 EXPRESSION TAG SEQADV 4R1E GLY B 802 UNP Q8IDR3 SEE REMARK 999 SEQRES 1 A 145 GLY SER VAL ALA ASP ILE GLN GLN LEU GLU GLU LYS VAL SEQRES 2 A 145 ASP GLU SER ASP VAL ARG ILE TYR PHE ASN GLU LYS SER SEQRES 3 A 145 SER GLY GLY LYS ILE SER ILE ASP ASN ALA SER TYR ASN SEQRES 4 A 145 ALA ARG LYS LEU GLY LEU ALA PRO SER SER ILE ASP GLU SEQRES 5 A 145 LYS LYS ILE LYS GLU LEU TYR GLY ASP ASN LEU THR TYR SEQRES 6 A 145 GLU GLN TYR LEU GLU TYR LEU SER ILE CYS VAL HIS ASP SEQRES 7 A 145 LYS ASP ASN VAL GLU GLU LEU ILE LYS MET PHE ALA HIS SEQRES 8 A 145 PHE ASP ASN ASN CYS THR GLY TYR LEU THR LYS SER GLN SEQRES 9 A 145 MET LYS ASN ILE LEU THR THR TRP GLY ASP ALA LEU THR SEQRES 10 A 145 ASP GLN GLU ALA ILE ASP ALA LEU ASN ALA PHE SER SER SEQRES 11 A 145 GLU ASP ASN ILE ASP TYR LYS LEU PHE CYS GLU ASP ILE SEQRES 12 A 145 LEU GLN SEQRES 1 B 15 GLY SER LEU LEU ARG VAL GLN ALA HIS ILE ARG LYS LYS SEQRES 2 B 15 MET VAL HET 3EC B 901 12 HETNAM 3EC 5-{[(2-AMINOETHYL)SULFANYL]METHYL}FURAN-2-CARBALDEHYDE FORMUL 3 3EC C8 H11 N O2 S FORMUL 4 HOH *67(H2 O) HELIX 1 1 ASP A 73 SER A 85 1 13 HELIX 2 2 ILE A 92 LEU A 102 1 11 HELIX 3 3 SER A 107 GLY A 119 1 13 HELIX 4 4 THR A 123 CYS A 134 1 12 HELIX 5 5 ASN A 140 HIS A 150 1 11 HELIX 6 6 LYS A 161 TRP A 171 1 11 HELIX 7 7 THR A 176 SER A 188 1 13 HELIX 8 8 TYR A 195 GLN A 204 1 10 HELIX 9 9 SER B 803 VAL B 816 1 14 SHEET 1 A 2 ILE A 90 SER A 91 0 SHEET 2 A 2 ASN A 121 LEU A 122 -1 O LEU A 122 N ILE A 90 SHEET 1 B 2 TYR A 158 THR A 160 0 SHEET 2 B 2 ASN A 192 ASP A 194 -1 O ILE A 193 N LEU A 159 LINK N GLY B 802 CAL 3EC B 901 1555 1555 1.32 SITE 1 AC1 6 GLY A 172 ASP A 173 GLY B 802 SER B 803 SITE 2 AC1 6 LEU B 804 LEU B 805 SITE 1 AC2 32 TYR A 97 ARG A 100 LYS A 101 GLY A 103 SITE 2 AC2 32 LEU A 104 ALA A 105 PRO A 106 HIS A 136 SITE 3 AC2 32 ASP A 139 GLU A 143 LEU A 144 MET A 147 SITE 4 AC2 32 LEU A 168 TRP A 171 GLY A 172 ASP A 173 SITE 5 AC2 32 ALA A 174 LEU A 175 GLU A 179 ALA A 183 SITE 6 AC2 32 PHE A 198 ASP A 201 ILE A 202 LEU A 203 SITE 7 AC2 32 GLN A 204 HOH A 301 HOH A 307 HOH A 316 SITE 8 AC2 32 GLY B 802 3EC B 901 HOH B1001 HOH B1004 CRYST1 36.710 55.760 75.860 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.027241 0.000000 0.000000 0.00000 SCALE2 0.000000 0.017934 0.000000 0.00000 SCALE3 0.000000 0.000000 0.013182 0.00000